Here are three things to know:
1. Shai Yarkoni, MD, PhD, and Nuriel Chirich Kasbian co-founded the company in 2011.
2. Cellect recently received several patent grants for its Apograft technology, which is designed to replace costly and complex stem cell isolation methods.
3. Apograft-using devices are intended for bone marrow transplants, diabetes, inflammatory bowel disease, graft-versus-host-disease and more.
More articles on biologics:
Bio2 Technologies to begin enrolling patients in cervical interbody fusion device trial: 3 insights
3 things to know about Kuros Biosciences’ CEO
3 things to know about Histogenics
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.